Skip to main content

Medicine Matters branded image Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in oncology

New additions to the Adis Journal Club – December update

Targeted Oncology Journal

Browse December's selection of peer-reviewed articles from the Adis journal portfolio. Curated by the editors and updated monthly. These papers highlight topical research and reviews for the benefit of Medicine Matters readers.



IN FOCUS | Lung & thoracic cancers

12-11-2021 | Non-small-cell lung cancer | News

EGFR-positive NSCLC recurrence patterns explored

People with EGFR-positive non-small-cell lung cancer may benefit from individualized risk-profiling, say researchers who observed a high recurrence risk following resection but also identified a subgroup that may be cured without adjuvant osimertinib.

IN FOCUS | Genitourinary cancers

23-11-2021 | Prostate cancer | News

Treatment-related regret common in localized prostate cancer patients

Around 10% of men with localized prostate cancer experience treatment-related regret but this rate varies by treatment modality and is mediated by posttreatment functional outcomes and patient expectations, study findings indicate.

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox

IN FOCUS | Breast cancer

20-10-2021 | Breast cancer | News

Earlier breast screening for Black women may reduce racial mortality gaps

Initiating biennial breast screening for Black women at age 40 years rather than the US standard of 50 years could substantially reduce Black–White breast cancer mortality disparities without increasing harms, modelling data suggest.

IN FOCUS | COVID-19 & cancer

03-11-2021 | COVID-19 | News

SARS-CoV-2 humoral, cellular immunity in people with cancer characterized

Two papers from the prospective, longitudinal UK CAPTURE consortium shed light on the humoral and cellular immune response to SARS-CoV-2 vaccination and infection in patients with cancer.


Interviews with clinical experts on cancer patient care

Image Credits